Carlyle buys stake in pharma firm Ambio

The private equity firm plans to help the pharmaceutical firm expand in China.

The Carlyle Group said on Monday it has acquired a significant minority stake in North Augusta, South Carolina-headquartered Ambio Holdings from specialist healthcare fund MVM Partners.

Founded in 2007 by Chris Bai, Ambio develops and manufactures peptide active pharmaceutical ingredients.

Both target and buyer hope the deal will be a first step towards expansion in China, where a burgeoning middle class and disquiet over a dysfunctional medical system are creating a host of opportunities for investors

“Carlyle Asia team’s strong local connections will help expedite our growth strategies in China,” Bai said.

Equity for the investment came from Carlyle...

¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222